Blood and scan markers in acute pancreatitis
Part of Digestive system clinical trials.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old when you join
- You have been diagnosed with acute pancreatitis (a sudden pancreas inflammation) based on symptoms, blood tests, and/or imaging
- The research team contacts you within 36 hours of coming to the hospital
- You can understand the study and agree to consent, interviews/forms, and blood/tissue sample collection
- You do not have definite chronic pancreatitis, a pancreas tumor, or certain pancreas-related cyst conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
This study looks at how acute pancreatitis affects blood sugar and the risk of developing diabetes. You'll wear a continuous glucose monitor (CGM) sensor and have metabolic tests to track changes over time.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This study looks at how gut bacteria change during acute pancreatitis and whether analyzing them can help predict how severe the condition will become. It may lead to better treatments and faster recovery.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.